1-(2-Methyl-2,3-dihydro-benzofuran-5-YL)-propylamine 、 吡啶-2-甲醛 以to give the title compound as a yellow oil (190 mg, 72%)的产率得到1-(2-methyl-2,3-dihydro-1-benzofuran-5-yl)-N-(pyridin-2-ylmethyl)propan-1-amine
The present invention relates to Kv1.3 potassium channel blockers of Formula (I) and their use in the treatment of autoimmune and inflammatory diseases.